{"product_id":"michigan-medicine-18th-annual-advanced-liver-disease-and-liver-transplantation-update-2024","title":"Michigan Medicine 18th Annual Advanced Liver Disease and Liver Transplantation Update 2024","description":"\u003cheader class=\"section__headings section__headings___edc6e\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"field field-name-field-course-summary field-type-text-with-summary field-label-hidden\"\u003e\n\u003cdiv class=\"field-items\"\u003e\n\u003cdiv class=\"field-item even\"\u003e\n\u003cdiv class=\"card-header bg-transparent py-4 px-3\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"bundle--paragraph_component paragraph paragraph--type--paragraph-component paragraph--view-mode--default\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"row\"\u003e\n\u003cdiv class=\"columns small-12 medium-12 large-12 sidebar-full\"\u003e\n\u003cdiv class=\"prod-title\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv\u003e\n\u003ch3 class=\"product_title entry-title\"\u003eMichigan Medicine 18th Annual Advanced Liver Disease and Liver Transplantation Update 2024\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\u003cstrong\u003eInclude: 10 videos + 1 pdf, size: 4.06 GB\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eThis course is to provide an update on recent developments in the management of patients with advanced liver disease including recent improvements in the management of Metabolic Associated liver disease, GI and Hepatic side effects immunotherapy, and use of TIPS for complications of portal hypertension.\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eIn addition, updates on MELD 3.0 in liver transplantation allocation, managing alcohol use disorder, assessment and management of frail LT candidates, how to assess coronary artery disease in patients with cirrhosis, and the use of extracorporeal machine perfusion of donor livers will be provided. After completing this activity, participants will understand and be able to implement in their practice recent developments in the management of patients with advanced liver disease.\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cp\u003eThis activity is appropriate for:\u003cbr\u003e\n\u003cem\u003eHouse Officers, Nurse Practitioners, Nurses, Other Healthcare Professionals, Physician Assistants, Physicians, Social Workers\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cp\u003eIn the fields of:\u003cbr\u003e\n\u003cem\u003eFamily Medicine, Gastroenterology, General Medicine, Hepatology, Internal Medicine, Primary Care, Surgery, Transplant Surgery\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003ch3\u003eLearning Objectives\u003c\/h3\u003e\n\u003cp\u003eAt the end of this activity, participant will understand and be able to implement:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNewer approaches to the use of weight loss agents and other medications in patients with metabolic associated liver disease\u003c\/li\u003e\n\u003cli\u003eAppropriate diagnostic tools and treatment strategies for patients with Immunotherapy related colitis and hepatitis\u003c\/li\u003e\n\u003cli\u003eHow and when to place a TIPS for cirrhotics with GI bleeding and refractory ascites\u003c\/li\u003e\n\u003cli\u003eUse of the MELD 3.0 scoring system in liver transplant candidates\u003c\/li\u003e\n\u003cli\u003eHow to assess and treat malnutrition and fraility in patients with advanced cirrhosis\u003c\/li\u003e\n\u003cli\u003eHow to diagnose and treat coronary artery disease and valvular heart disease in patients with cirrhosis\u003c\/li\u003e\n\u003cli\u003ePotential use of normothermic and hypothermic perfusion of livers in the transplant setting\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e18thannualliverroundup2024010924_0111_101946.pdf\u003cbr\u003e\nAssessment and Management of Frail Liver Transplant Candidates.mp4\u003cbr\u003e\nCheckpoint Inhibitor Hepatitis \u0026amp; Colitis.mp4\u003cbr\u003e\nDiagnosis and Treatment of Coronary Artery Disease and Valvular Heart Disease in Cirrhosis.mp4\u003cbr\u003e\nInteractive Case 1- A Transplant Candidate with AUD .mp4\u003cbr\u003e\nMachine Perfusion of Donor Organs.mp4\u003cbr\u003e\nManaging Alcohol Use Disorder (AUD) in ALD Patients.mp4\u003cbr\u003e\nMELD 3.0 in Liver Transplantation.mp4\u003cbr\u003e\nPanel Questions \u0026amp; Answers Part 1 Q\u0026amp;A (MASLD, Immunotherapy, Portal Hypertension, Liver Allocation, Alcohol Use Disorder).mp4\u003cbr\u003e\nTIPS for Complications of Portal Hypertension.mp4\u003cbr\u003e\nWeight Loss Agents \u0026amp; Medical Therapy for MASLD.mp4\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/header\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954602283106,"sku":"MED-AMB06847","price":25.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Michigan-Medicine-18th-Annual-Advanced-Liver-Disease-and-Liver-Transplantation-Update-2024.jpg?v=1779380459","url":"https:\/\/meducourse.com\/products\/michigan-medicine-18th-annual-advanced-liver-disease-and-liver-transplantation-update-2024","provider":"Meducourse","version":"1.0","type":"link"}